RATIONALE: The adenosine A3 receptor and the nitric oxide (NO) pathway regulate the function and localization of serotonin transporters (SERTs). These transporters regulate extracellular serotonin levels, which are correlated with defensive behavior. OBJECTIVE: The purpose of this study was to understand the role of the A3AR on anxiety and arousal models in zebrafish, and whether this role is mediated by the nitrergic modulation of serotonin uptake. METHODS: The effects of IB-MECA (0.01 and 0.1 mg/kg) were assessed in a series of behavioral tasks in adult zebrafish, as well as on extracellular serotonin levels in vivo and serotonin uptake in brain homogenates. Finally, the interaction between IB-MECA and drugs blocking voltage-dependent calcium channels (VDCCs), NO synthase, and SERT was analyzed. RESULTS: At the lowest dose, IB-MECA decreased bottom dwelling and scototaxis, while at the highest dose, it also decreased shoaling, startle probability, and melanophore responses. These effects were accompanied by an increase in brain extracellular serotonin levels. IB-MECA also concentration-dependently increased serotonin uptake in vitro. The effects of IB-MECA on extracellular 5-HT, scototaxis, and geotaxis were blocked by L-NAME, while only the effects on 5-HT and scototaxis were blocked by verapamil. In vitro, the increase in 5-HT uptake was dependent on VDCCs and NO. Finally, fluoxetine blocked the effect of IB-MECA on scototaxis, but not geotaxis. CONCLUSION: These results suggest that the effect of IB-MECA on scototaxis are mediated by a VDCC-NO-SERT pathway. While NO seems to mediate the effects of IB-MECA on geotaxis, neither VDCCs nor SERT seems to be involved in this process.
RATIONALE: The adenosine A3 receptor and the nitric oxide (NO) pathway regulate the function and localization of serotonin transporters (SERTs). These transporters regulate extracellular serotonin levels, which are correlated with defensive behavior. OBJECTIVE: The purpose of this study was to understand the role of the A3AR on anxiety and arousal models in zebrafish, and whether this role is mediated by the nitrergic modulation of serotonin uptake. METHODS: The effects of IB-MECA (0.01 and 0.1 mg/kg) were assessed in a series of behavioral tasks in adult zebrafish, as well as on extracellular serotonin levels in vivo and serotonin uptake in brain homogenates. Finally, the interaction between IB-MECA and drugs blocking voltage-dependent calcium channels (VDCCs), NO synthase, and SERT was analyzed. RESULTS: At the lowest dose, IB-MECA decreased bottom dwelling and scototaxis, while at the highest dose, it also decreased shoaling, startle probability, and melanophore responses. These effects were accompanied by an increase in brain extracellular serotonin levels. IB-MECA also concentration-dependently increased serotonin uptake in vitro. The effects of IB-MECA on extracellular 5-HT, scototaxis, and geotaxis were blocked by L-NAME, while only the effects on 5-HT and scototaxis were blocked by verapamil. In vitro, the increase in 5-HT uptake was dependent on VDCCs and NO. Finally, fluoxetine blocked the effect of IB-MECA on scototaxis, but not geotaxis. CONCLUSION: These results suggest that the effect of IB-MECA on scototaxis are mediated by a VDCC-NO-SERT pathway. While NO seems to mediate the effects of IB-MECA on geotaxis, neither VDCCs nor SERT seems to be involved in this process.
Authors: William H J Norton; Katharina Stumpenhorst; Theresa Faus-Kessler; Anja Folchert; Nicolas Rohner; Matthew P Harris; Jacques Callebert; Laure Bally-Cuif Journal: J Neurosci Date: 2011-09-28 Impact factor: 6.167
Authors: Caio Maximino; Monica G Lima; Karen R M Olivera; Domingos L W Picanço-Diniz; Anderson M Herculano Journal: Basic Clin Pharmacol Toxicol Date: 2011-05-23 Impact factor: 4.080
Authors: Jerry C Chang; Ian D Tomlinson; Michael R Warnement; Alessandro Ustione; Ana M D Carneiro; David W Piston; Randy D Blakely; Sandra J Rosenthal Journal: J Neurosci Date: 2012-06-27 Impact factor: 6.167
Authors: B Chanrion; C Mannoury la Cour; F Bertaso; M Lerner-Natoli; M Freissmuth; M J Millan; J Bockaert; P Marin Journal: Proc Natl Acad Sci U S A Date: 2007-04-23 Impact factor: 11.205
Authors: Chong-Bin Zhu; Jennifer A Steiner; Jaclyn L Munn; Lynette C Daws; William A Hewlett; Randy D Blakely Journal: J Pharmacol Exp Ther Date: 2007-04-25 Impact factor: 4.030
Authors: Caio Maximino; Rhayra Xavier do Carmo Silva; Suéllen de Nazaré Santos da Silva; Laís do Socorro Dos Santos Rodrigues; Hellen Barbosa; Tayana Silva de Carvalho; Luana Ketlen Dos Reis Leão; Monica Gomes Lima; Karen Renata Matos Oliveira; Anderson Manoel Herculano Journal: Front Behav Neurosci Date: 2015-09-08 Impact factor: 3.558
Authors: Vania Murcia; Luke Johnson; Meredith Baldasare; Bridgette Pouliot; John McKelvey; Brandon Barbery; Julie Lozier; Wade E Bell; James E Turner Journal: Toxics Date: 2016-09-26